By Lisa Thompson NASDAQ:TSEM READ THE FULL TSEM RESEARCH REPORT Tower (NASDAQ:TSEM) continued year-over-year revenue growth in Q4 2024 and expects that to continue sequentially and year-over-year throughout 2025. The growth will be back-half weighted as capacity comes online in Italy, Texas, and Japan. For the 2024 year, revenues and earnings were basically flat with … Read more
By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT On January 3, 2025, CytoSorbents (NASDAQ:CTSO) reported strong preliminary 4th quarter and full year 2024 financial results which exceeded our expectations. 4th quarter product revenue (excluding grant income) is estimated to be in the range of $9.0-$9.2 million, which is approximately 22% to 25% … Read more
By Lisa Thompson OTC:CLPMF READ THE FULL CLPMF RESEARCH REPORT Revenue is ramping even faster than we expected, as shown by the Q3 earnings report. Revenue for Q3 2024 was $521,000 compared to $149,000 in Q3 of 2023, representing 250% growth. In the quarter, the number of new deposit users grew by 101%, and revenue … Read more
Last week, actor and director Ben Affleck shared his views on AI’s role in filmmaking during the 2024 CNBC Delivering Alpha investor summit, arguing that AI models will transform visual effects but won’t replace creative filmmaking anytime soon. A video clip of Affleck’s opinion began circulating widely on social media not long after. “Didn’t expect … Read more
By Lisa Thompson NYSE:MHH READ THE FULL MHH RESEARCH REPORT After seven quarters of declining year-over-year revenues, Mastech (NYSE:MHH) reported revenue growth of 8.5% in Q3 2024. Gross margin was again at an all-time high, and income is growing faster than revenues. As a result, we are raising our Q4 2024 and 2025 EPS estimates … Read more
